Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Prevention and Cessation of Cigarette Smoking: Control of Tobacco Use (PDQ®)
Patient Version
Health Professional Version
Last Modified:
05/01/2008
Table 7. Varenicline
Brand
Dose
Side Effects
Warning/Precaution
d = day; Rx = prescription; wk = week.
Rx
Chantix
0.5 mg/d, d 1–3; 0.5 mg twice a d, d 4–7; then 1.0 mg twice a d through wk 12
Nausea, insomnia
Risk of toxicity greater in patients with impaired renal function
Not tested in children and pregnant women
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute